Tag: biotech
AI Integration and Federal Policy Shape Biotech Industry Outlook at BIO 2026
Artificial intelligence and federal regulatory policy dominated discussions at BIO International Convention 2026 in San Diego. Industry leaders expressed cautious…
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
AI-Driven Depression Treatment Platform Neumora Halts Clinical Development
Neumora, an AI-focused depression treatment platform backed by venture capital firm ARCH, has halted its clinical development program. The closure…
Biotech Innovation Thrives Despite US Leadership Challenges, Industry Veteran Warns
Biotech industry delivers unprecedented breakthroughs while facing mounting challenges to US leadership from regulatory delays, funding constraints, and international competition.…
AI Drug Development Faces Reality Check as BigHat CEO Debunks Industry Hype
BigHat Biosciences CEO warns that misconceptions about AI capabilities threaten genuine progress in computational drug discovery. Despite $50 billion annual…